“It’s important to acknowledge that every state and actor cannot do the same thing. But we all share the responsibility to act and to collaborate.”
-Daniel Carelli
Across the New Conceptions miniseries, we’ve made the case that AMR must be addressed not only as a biomedical challenge but also as a social challenge. We’ve explored a series of conceptions that can reshape the global action plan revisions: antimicrobial resistance as socio-ecological dynamics, as infrastructure woven through daily life, and as a challenge shaped by urbanization, social inequities, and global systems.
In this episode of Unpacking AMR, Daniela Corno speaks with Dr. Laura Valtere and Dr. Daniel Carelli to unpack AMR as a collective action problem, a global challenge that cuts across human, animal, plant, and environmental health, and pulls in players from industry, academia, healthcare, and civil society. It’s a vast patchwork of actors, each with their own competing interests and limited incentives to cooperate across borders. Together they explore how resistance pays no attention to national borders, why national action plans often fall short of their promises, and what it might take to build the trust, capacity, and authority that real cooperation demands.
This is the fourth and final episode in our “New Conceptions to Manage AMR” miniseries, which has explored how social science can reframe the way we think about antimicrobial resistance and strengthen the next global action plan. It’s the last of the series, but not of the podcast! Stay tuned for more episodes of Unpacking AMR.
Listen to the other episodes:
Also listen on:
Guests
Dr. Laura Valtere is a postdoctoral fellow at the Centre for Advanced Studies in Bioscience Innovation Law (CeBIL) in the Faculty of Law at the University of Copenhagen. She holds a PhD from the Max Planck Institute for Innovation and Competition, and her research focuses on patent law and regulatory frameworks in biotechnology and pharmaceuticals, including the use of exclusivity as an incentive tool and, most recently, the role of intellectual property and regulation in combating antimicrobial resistance.
Dr. Daniel Carelli is a postdoctoral researcher at Chalmers University of Technology in Gothenburg, Sweden, and holds a PhD in political science from the University of Gothenburg. His research examines how contemporary states function and how they can be organized to tackle major global challenges such as climate change, pandemics, and antimicrobial resistance, with a particular interest in the role of bureaucratic institutions in these efforts.
Thank you to our behind-the-scenes crew for their support on this episode: Sofía Gutiérrez, Rosemary Vu, Kayla Strong, Daniela Corno and Demetria Tsoutouras.
[Transcript coming soon]
Resources:
- Using Social Sciences to Inform the Global Action Plan on AMR
- The social burden of antimicrobial resistance: what is it, how can we measure it, and why does it matter?
- SAFE AMR Partnership
- Unpacking AMR episodes
- Analyzing Antimicrobial Resistance as a Series of Collective Action Issues
- Free riding is not the problem: how agency, heterogeneity and authority challenge collective action against antimicrobial resistance in the European Union
- Drivers of transnational administrative coordination on super-wicked policy issues: The role of institutional homophily
Episodes
Previous